|Articles|September 1, 2001
Supplements and Featured Publications
- Depression and Generalized Anxiety Disorder: Managed Care Considerations
- Volume 7
- Issue 11 Suppl
The Clinical, Psychosocial, and Pharmacoeconomic Ramifications of Remission
Author(s)Michael E. Thase, MD
Advertisement
Articles in this issue
over 24 years ago
Participating Facultyover 24 years ago
Introductionover 24 years ago
The Pharmacoeconomics of Venlafaxine in DepressionNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
How Do GLP-1 Agonists Fit Into Stroke Care?
3
Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD
4
Aligning Treatment Goals in IgA Nephropathy: Applying KDIGO’s Dual-Pathway Framework to Clinical Decision-Making
5
